They were obtained from prodromal DLB (pro-DLB), DLB dementia, prodromal AD (pro-AD), and AD dementia patients, and elderly controls (phospho-Tau181, total-Tau, Aβ42, and Aβ40). The gene discussed is MAPT; the disease is Alzheimer disease.